The U.S. Food and Drug Administration’s database indicates that the abbreviated new drug application (ANDA) 087157 for the product FLUONID has a marketing status of "Discontinued." FLUONID is a topical ointment containing 0.025% fluocinonide. The product is not designated as a reference drug and does not have a reference standard. The sponsor listed for this ANDA is Allergan Herbert. No further details on the reason for discontinuation are provided in the FDA entry.
Actualizaciones regulatorias5 sept 2026•1 min de lectura
FDA Discontinues FLUONID Topical Ointment (ANDA 087157)
The FDA lists the FLUONID ointment (0.025% fluocinonide) under ANDA 087157 as discontinued, sponsored by Allergan Herbert.
Recopilado por el equipo de PharmaCountry · Fuente: FDA.gov
Calificaciones
(0)
(0)
(0)
(0)
(0)
Más artículos
Ver todos los artículosInvestigación e Informes
Global Finished Dosage Manufacturing Landscape 2026
5 oct 2026
Actualizaciones regulatoriasKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept 2026
AnálisisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept 2026
Deja tu valoración